Anzeige
Mehr »
Login
Dienstag, 04.03.2025 Börsentäglich über 12.000 News von 689 internationalen Medien
Mit Vollgas Richtung Expansion - Gelingt nun der Durchbruch?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2H7JW | ISIN: SE0010468116 | Ticker-Symbol: A39
Tradegate
03.03.25
14:38 Uhr
3,526 Euro
+0,034
+0,97 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ARJO AB Chart 1 Jahr
5-Tage-Chart
ARJO AB 5-Tage-Chart
RealtimeGeldBriefZeit
3,4303,46410:29
3,4363,45610:29
GlobeNewswire (Europe)
83 Leser
Artikel bewerten:
(0)

Arjo AB: Arjo's year-end report January-December 2024

Finanznachrichten News

"We close the year with a solid fourth quarter with growth and increased profitability. We have a strong foundation to stand on and enter 2025 with positive momentum in key markets such as the US and UK. In parallel, we remain committed to our efforts for continued profitability improvements moving forward," says Niclas Sjöswärd, Interim President & CEO of Arjo.

October-December 2024 in brief

  • Net sales increased to SEK 2,989 M (2,879). Net sales grew organically by 3.1%.
  • The gross margin was 44.7% (45.3).
  • Adjusted EBITDA increased 6.5% to SEK 653 M (614).
  • Adjusted operating profit increased 9.7% to SEK 375 M (342).
  • Profit after financial items increased to SEK 245 M (242).
  • Earnings per share amounted to SEK 0.64 (0.67).
  • Cash flow from operations amounted to SEK 479 M (734), corresponding to a cash conversion of 82.3% (124.6).
  • A dividend per share of SEK 0.95 (0.90) is proposed, corresponding to approximately SEK 259 M.

Key events after the end of the quarter:

  • CFO Niclas Sjöswärd was appointed interim President & CEO after Joacim Lindoff left his position. Christofer Carlsson appointed interim CFO.
  • Global launch of the new bathing system Symbliss.

Telephone conference

Fund managers, analysts and media are invited to participate in a conference call and presentation of the report on January 30 at 08:00 CET via the following link: https://arjo.events.inderes.com/q4-report-2024

Those who wish to ask questions verbally during the teleconference will need to register via the link below. A phone number and a conference ID will be provided after registration in order to access the conference. Link to registration:
https://conference.inderes.com/teleconference/?id=5007713

Alternatively, use the following link to download the presentation: https://www.arjo.com/int/about-us/investors/reports--presentations/2025/

A recorded version of the conference is accessible for three years via the following link: https://arjo.events.inderes.com/q4-report-2024


For more information, please contact:

Maria Nilsson, EVP Communications & Public Relations

Tel: +46 734 244 515

Email: maria.nilsson@arjo.com


This information is information that Arjo AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 07:00 CET on January 30, 2025.


About Arjo

At Arjo, we believe that empowering movement within healthcare environments is essential to quality care. Our products and solutions are designed to promote a safe and dignified experience through patient handling, medical beds, personal hygiene, disinfection, diagnostics, and the prevention of pressure injuries and venous thromboembolism. With more than 6,500 people worldwide and over 65 years caring for patients and healthcare professionals, we are committed to driving healthier outcomes for people facing mobility challenges. www.arjo.com

© 2025 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.